| Evaluation of the Role of Aflatoxin as an Environmental Risk Factor Attributable to Liver Cancer in Nile Delta (NCT02461966) | Sherief Abd-Elsalam | 2014-06-01 |
| Postoperative Heme Oxygenase Induction and Carbon Monoxide Production as a Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy (NCT04195438) | University of Maryland, Baltimore | 2014-05-07 |
| Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease (NCT01864070) | M.D. Anderson Cancer Center | 2014-05-01 |
| A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC) (NCT02029157) | Kyowa Kirin Co., Ltd. | 2014-01-01 |
| Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer (NCT02069145) | OncoMed Pharmaceuticals, Inc. | 2014-01-01 |
| Fusion Guided Thermal Ablation Combined With External Beam Radiation for Hepatic Neoplasms (NCT01862718) | National Institutes of Health Clinical Center (CC) | 2013-11-19 |
| Integrated Cancer Repository for Cancer Research (NCT02012699) | University of Nebraska | 2013-11-01 |
| Study of New Software Used During Ablations (NCT01906021) | National Institutes of Health Clinical Center (CC) | 2013-09-23 |
| Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma (NCT01932385) | Qingdao Central Hospital | 2013-08-01 |
| Engagement of Patients With Advanced Cancer (NCT02966509) | Stanford University | 2013-08-01 |
| Safety and Efficacy Study of DCVax-Direct in Solid Tumors (NCT01882946) | Northwest Biotherapeutics | 2013-06-01 |
| Tremelimumab With Chemoembolization or Ablation for Liver Cancer (NCT01853618) | National Cancer Institute (NCI) | 2013-05-02 |
| Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors (NCT02202317) | University of Miami | 2013-04-01 |
| Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer (NCT01877187) | Yale University | 2013-04-01 |
| Platform for Medical Information Extraction From Incomplete Data (NCT01813942) | National Taiwan University Hospital | 2013-03-01 |
| Pre-procedure Planning for Radiofrequency Ablation Using CT or MR/US Fusion (NCT02687113) | Seoul National University Hospital | 2013-03-01 |
| Effectivity and Safety of Ultrasound-guided Percutaneously Radiofrequency Ablation for Liver Cancer (NCT03026452) | First Affiliated Hospital of Zhejiang University | 2013-01-01 |
| Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer (NCT02324127) | Protgen Ltd | 2012-10-01 |
| Collecting Solid Tumor Tissue to Identify New Treatments (NCT01658917) | National Cancer Institute (NCI) | 2012-07-24 |
| A Phase I Study of Recombinant hGM-CSF Herpes Simplex Virus to Treat Cancer (NCT01935453) | OrienGene Biotechnology Ltd. | 2012-05-01 |
| Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets (NCT01581307) | H. Lee Moffitt Cancer Center and Research Institute | 2012-04-01 |
| Immunotherapy of Tumor With Autologous Tumor Derived Heat Shock Protein gp96 (NCT02133079) | Cure&Sure Biotech Co., LTD | 2012-03-01 |
| Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-Controlled Analgesia For Liver and/or Pancreas (NCT01438476) | M.D. Anderson Cancer Center | 2012-01-26 |
| A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib (NCT01387555) | Jennerex Biotherapeutics | 2011-10-08 |
| A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection (NCT01402908) | Cellxpert Biotechnology Corp. | 2011-08-01 |
| A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer (NCT01356628) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-05-25 |
| Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer (NCT01353300) | Children's Oncology Group | 2011-05-01 |
| Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies (NCT01401907) | Massachusetts General Hospital | 2011-05-01 |
| Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy (NCT01180959) | M.D. Anderson Cancer Center | 2011-04-14 |
| Observational Study of the Decision Making Towards Clinical Trials in Cancer Patients (NCT01341210) | National Taiwan University Hospital | 2011-02-01 |
| Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation (NCT01151761) | Stanford University | 2011-01-01 |
| Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures (NCT01286428) | Pathfinder Therapeutics | 2011-01-01 |
| Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer (NCT01264705) | University of Texas Southwestern Medical Center | 2011-01-01 |
| Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy (NCT01082224) | American College of Radiology Imaging Network | 2010-12-01 |
| Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures (NCT01238653) | Pathfinder Therapeutics | 2010-11-01 |
| Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery (NCT01324076) | University College, London | 2010-11-01 |
| Evaluation of a Minimally Invasive Image-Guided Surgery System for Hepatic Ablation Procedures (NCT01238666) | Pathfinder Therapeutics | 2010-11-01 |
| Perception Prognosis, Goals of Treatment, and Communication (NCT01401894) | Massachusetts General Hospital | 2010-10-01 |
| Real-time Diagnosis of Serum LECT 2 in Patient With Liver Cancer Using Electronic Antibody Sensor (e- Ab Sensor) (NCT01388101) | National Taiwan University Hospital | 2010-09-01 |
| Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer (NCT01185639) | Wake Forest University Health Sciences | 2010-08-01 |
| Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures (NCT01237990) | Pathfinder Therapeutics | 2010-08-01 |
| CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer (NCT01033240) | Daiichi Sankyo | 2010-07-09 |
| Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer (NCT01164202) | Federation Francophone de Cancerologie Digestive | 2010-07-01 |
| A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors (NCT01171924) | Curis, Inc. | 2010-07-01 |
| Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery (NCT01182272) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2010-05-01 |
| The Inflammatory Response to Stress and Angiogenesis in Liver Resection (NCT03131778) | University Hospital, Ghent | 2010-04-01 |
| IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread (NCT01099631) | Masonic Cancer Center, University of Minnesota | 2010-04-01 |
| Sharable Knowledge Mining Platform (NCT01178801) | National Taiwan University Hospital | 2010-03-01 |
| Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer (NCT02321202) | Huazhong University of Science and Technology | 2010-03-01 |
| Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors (NCT01075399) | Siemens Molecular Imaging | 2010-02-01 |
| Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis (NCT01075555) | Federation Francophone de Cancerologie Digestive | 2010-02-01 |
| Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer (NCT01009801) | Swiss Cancer Institute | 2010-02-01 |
| A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support (NCT01292330) | Peking Union Medical College Hospital | 2010-01-01 |
| Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis (NCT01079767) | Federation Francophone de Cancerologie Digestive | 2010-01-01 |
| Autologous Immune Killer Cells to Treat Liver Cancer Patients as an Adjunct Therapy (NCT03592706) | Ivy Life Sciences, Co., Ltd | 2009-12-01 |
| Trial of Bi-shRNA-furin and GMCSF Augmented Autologous Tumor Cell Vaccine for Advanced Cancer (NCT01061840) | Gradalis, Inc. | 2009-12-01 |
| Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer (NCT01005199) | Swiss Cancer Institute | 2009-11-01 |
| Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer (NCT00987766) | Vanderbilt-Ingram Cancer Center | 2009-11-01 |
| Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma (NCT01005875) | University of Alabama at Birmingham | 2009-11-01 |
| Examinations of Tissue From Ablated Malignant Liver Metastases as Predictors of Outcome (NCT01494324) | Memorial Sloan Kettering Cancer Center | 2009-10-27 |
| A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer (NCT01522937) | University of Michigan Rogel Cancer Center | 2009-10-01 |
| HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver (NCT00980239) | M.D. Anderson Cancer Center | 2009-09-01 |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer (NCT01042041) | Abramson Cancer Center at Penn Medicine | 2009-09-01 |
| Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer (NCT00903396) | Alliance for Clinical Trials in Oncology | 2009-09-01 |
| Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery (NCT00956930) | Northwestern University | 2009-08-01 |
| Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma (NCT00976898) | Massachusetts General Hospital | 2009-08-01 |
| Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery (NCT01313377) | UNICANCER | 2009-07-01 |
| Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery (NCT00949182) | Rutgers, The State University of New Jersey | 2009-07-01 |
| Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma (NCT00669136) | Lisa H. Butterfield, Ph.D. | 2009-06-01 |
| Acceptability of Less Harmful Alternatives to Cigarettes (NCT00957424) | Roswell Park Cancer Institute | 2009-06-01 |
| Clinical Evaluation of the New Hypoxia Imaging Agent HX4 (NCT01213030) | Siemens Molecular Imaging | 2009-06-01 |
| Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Metastatic Tumors to the Liver (NCT01030757) | New Mexico Cancer Research Alliance | 2009-06-01 |
| Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection (NCT00902343) | Memorial Sloan Kettering Cancer Center | 2009-05-01 |
| Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases (NCT00858429) | Northwestern University | 2009-04-01 |
| Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer (NCT00867321) | Alliance for Clinical Trials in Oncology | 2009-04-01 |
| Measurement of Pro-angiogenic Markers in Patients With Hepatic Metastases Undergoing SIRT (NCT00994370) | Rutgers, The State University of New Jersey | 2009-04-01 |
| TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis (NCT01556282) | Emory University | 2009-03-01 |
| Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery (NCT00873002) | Case Comprehensive Cancer Center | 2009-03-01 |
| Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer (NCT00881751) | Medical University of South Carolina | 2009-03-01 |
| Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment (NCT00825955) | Bristol-Myers Squibb | 2009-02-17 |
| Feasibility of Using Real-time Cine-MRI for Treating Moving & Deforming Tumors (NCT01071434) | Stanford University | 2009-02-01 |
| Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial (NCT00717756) | Brown University | 2009-01-01 |
| Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal Cancer (NCT00836992) | Mayo Clinic | 2009-01-01 |
| Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery (NCT00875615) | University of Miami | 2008-12-01 |
| Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer (NCT00941967) | Institut du Cancer de Montpellier - Val d'Aurelle | 2008-12-01 |
| Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer (NCT00950144) | City of Hope Medical Center | 2008-12-01 |
| Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery (NCT00777894) | Swiss Cancer Institute | 2008-11-01 |
| Prospective Liver Study (NCT01539993) | Emory University | 2008-11-01 |
| Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer (NCT00658593) | NCIC Clinical Trials Group | 2008-10-10 |
| The Feasibility of Using Anesthesia and Suspended Ventilation to Immobilize Liver Tumors During Radiotherapy (NCT00774501) | Memorial Sloan Kettering Cancer Center | 2008-10-01 |
| Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis (NCT00767468) | UNC Lineberger Comprehensive Cancer Center | 2008-10-01 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (NCT00790569) | Butler Hospital | 2008-09-01 |
| Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma (NCT00728078) | Sun Yat-sen University | 2008-07-01 |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy (NCT00716976) | Children's Oncology Group | 2008-06-23 |
| Genetic Analysis of Liver Cancer (NCT00768001) | Samuel So | 2008-06-01 |
| Hepatic Arterial Infusion (HAI) of Abraxane (NCT00732836) | M.D. Anderson Cancer Center | 2008-06-01 |
| Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer (NCT00654160) | Mayo Clinic | 2008-06-01 |
| Safety Study of Modified Vaccinia Virus to Cancer (NCT00574977) | David Bartlett | 2008-05-01 |
| Cancer Development In Organ Transplant Recipients (NCT02333279) | University of Zurich | 2008-05-01 |